Whos Using GLP-1s and Why According to the survey, 1 in 10 adults currently use a GLP-1 medication, and a further 42% say theyve seriously considered starting treatment
In the first portion of this study, the researchers discovered that the GLP-1 receptor acts as a negative costimulatory molecule in T lymphocytes
CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis
In isolated human enterocytes, approximately 75% of GLP-1-expressing cells express TGR5, whereas only 16% of GLP-1-negative cells do so, indicating that L cells are the predominant intestinal cell type responsive to TGR5 activation [150]
Available at: 10.1017/s2040174418000272
It must be emphasized, however, that to date the assay has been evaluated only with a limited number of chemicals, most of the analyses have been performed in a single laboratory, and the mechanistic basis of the model has not been established